Santhera Pharmaceuticals Holding AG (CHIX:SANNZ) Net Interest Margin (Bank Only) %


CHIX:SANNZ Santhera Pharmaceuticals Holding AG CHIX:SANNZ
47 GF Score
Price CHF14.84
GF Value CHF23.31
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Santhera Pharmaceuticals Holding AG Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

CHIX:SANNZ
47GF Score
Santhera Pharmaceuticals Holding AG CHIX:SANNZ
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Santhera Pharmaceuticals Holding AG (CHIX:SANNZ) Overvalued in 2026?

Based on GuruFocus' analysis, Santhera Pharmaceuticals Holding AG stock appears to be undervalued. The current stock price of CHF14.84 is trading 36.3% below its estimated GF Value™ of CHF23.31. GuruFocus considers Santhera Pharmaceuticals Holding AG to be Possible Value Trap.

Key valuation signals for CHIX:SANNZ:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: CHF23.31 vs. price of CHF14.84 (36.3% below fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the CHIX:SANNZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Santhera Pharmaceuticals Holding AG Business Description

Address Hohenrainstrasse 24, Pratteln, CHE, 4133
Santhera Pharmaceuticals Holding AG is a Swiss specialty pharmaceutical company committed to developing and commercializing medicines to meet the needs of patients living with rare and other diseases with high unmet medical needs. It is focused on the development of treatments for pulmonary and neuromuscular diseases that currently lack treatment options. The company is currently engaged in the rollout of its AGAMREE (vamorolone) medicine for the treatment of Duchenne muscular dystrophy (DMD) globally. Santhera has one operating segment, namely the development and commercialization of products for the treatment of neuromuscular diseases. Geographically, the company generates maximum revenue from Europe, and the rest from Asia and North America.
47GF Score

Get the complete analysis for CHIX:SANNZ

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF14.84
Price
CHF23.31
GF Value